State Street’s Microbot Medical MBOT Stock Holding History

State Street’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$732K	Buy	303,569 +96,400	+47%	+$215K	﹤0.01%	3561
2025 Q4	$414K	Sell	207,169 -1,300	-0.6%	-$3.08K	﹤0.01%	3726
2025 Q3	$636K	Buy	208,469 +69,949	+50%	+$218K	﹤0.01%	3608
2025 Q2	$349K	Buy	138,520 +1,850	+1%	+$4.43K	﹤0.01%	3693
2025 Q1	$206K	Buy	136,670 +110,600	+424%	+$196K	﹤0.01%	3817
2024 Q4	$29.2K	Hold	26,070	–	–	﹤0.01%	4190
2024 Q3	$23.3K	Hold	26,070	–	–	﹤0.01%	4210
2024 Q2	$26.6K	Hold	26,070	–	–	﹤0.01%	4242
2024 Q1	$32.1K	Hold	26,070	–	–	﹤0.01%	4232
2023 Q4	$42.8K	Hold	26,070	–	–	﹤0.01%	4221
2023 Q3	$36.2K	Hold	26,070	–	–	﹤0.01%	4352
2023 Q2	$70.9K	Hold	26,070	–	–	﹤0.01%	4314
2023 Q1	$54.2K	Hold	26,070	–	–	﹤0.01%	4484
2022 Q4	$78.5K	Hold	26,070	–	–	﹤0.01%	4441
2022 Q3	$125K	Hold	26,070	–	–	﹤0.01%	4374
2022 Q2	$134K	Buy	26,070 +800	+3%	+$4.45K	﹤0.01%	4381
2022 Q1	$158K	Sell	25,270 -9,500	-27%	-$55.7K	﹤0.01%	4469
2021 Q4	$261K	Hold	34,770	–	–	﹤0.01%	4237
2021 Q3	$244K	Buy	34,770 +300	+0.9%	+$2.17K	﹤0.01%	4287
2021 Q2	$274K	Buy	+34,470	New	+$260K	﹤0.01%	4092

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

State Street's MBOT Position: Q1 2026 in Review

State Street increased its Microbot Medical (MBOT) stake by 47% in Q1 2026, buying an estimated $215K and bringing the position to 303,569 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

State Street first reported a position in MBOT in Q2 2021 and has held it in 20 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

State Street held 303,569 shares of Microbot Medical worth $732K as of Q1 2026.
State Street bought 96,400 Microbot Medical shares in Q1 2026, an estimated $215K.
Microbot Medical made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3561 holding.
State Street first reported a position in Microbot Medical in Q2 2021 and has held it in 20 quarters since.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.